Clinical trial
The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in…
NCT00279201 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00279201 |
|---|---|
| Title | The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) |
| Official title | The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine When Added to Existing Oral Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control |
| Acronym | IOOV |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Insulin glargine, Lispro Low Mix, Lispro Mid Mix, Lispro |
| Enrollment | 2,091 |
| Start date | Dec 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 19, 2006 |
| Last update posted | Feb 21, 2011 |
| Countries | Argentina, Australia, Brazil, Canada, Greece, Hungary, India, Netherlands, Puerto Rico, Romania, Spain, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: